
ET’s calls to the helpline during the stipulated time remained unanswered. However, a J&J spokesperson told ET in an email response: “Our helpline team... is working diligently to assist ASR patients.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2CXWcvT
via
IFTTT
0 comments:
Post a Comment